Clinical Trials on Glabellar Crease
Total 10000 results
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
Ruth O'ReganUniversity of Rochester; Puma Biotechnology, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Active, not recruiting
-
BriaCell Therapeutics CorporationLumaBridgeCompletedBreast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Breast Cancer MetastaticUnited States
-
Fox Chase Cancer CenterUniversity of Wisconsin, MadisonActive, not recruitingCarcinoma Breast Stage IVUnited States
-
Chipscreen Biosciences, Ltd.TerminatedTriple-negative Breast CancerChina
-
University of Kansas Medical CenterMerck Sharp & Dohme LLCActive, not recruitingTriple-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Bryan Schneider, MDHoosier Cancer Research Network; Walther Cancer Institute; Vera Bradley Foundation... and other collaboratorsCompletedBreast Cancer | Malignant Neoplasm of BreastUnited States
-
SynCore Biotechnology Co., Ltd.Suspended
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Washington University School of MedicineSusan G. Komen Breast Cancer FoundationWithdrawnTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer
-
Taizhou Hanzhong biomedical co. LTDActive, not recruitingTriple-negative Breast CancerChina
-
Washington University School of MedicineSusan G. Komen Breast Cancer FoundationCompletedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast CancerUnited States
-
Eske Corporation S.A.CTerminatedBreast Cancer Stage IV | Breast Cancer Stage IIIA | Breast Cancer, Stage IIIBPeru
-
Texas Tech University Health Sciences Center, El...WithdrawnBreast Cancer | Metastatic Breast Cancer | HER-2 Positive Breast Cancer | ER Positive Breast Cancer
-
Indiana University School of MedicineBreast Cancer Research FoundationCompletedQuantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer (EPC)Breast Cancer Stage IV | Breast Cancer Stage I | Breast Cancer Stage IIUnited States
-
Craig A. Bunnell, MD, MPHMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage II Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7United States
-
The Methodist Hospital Research InstituteNovartis PharmaceuticalsRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Metaplastic Breast CarcinomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | Lobular Breast Carcinoma | Postmenopausal | Ductal Breast Carcinoma | Ductal Breast Carcinoma In SituUnited States
-
First Affiliated Hospital of Zhejiang UniversityActive, not recruitingBreast Reconstruction | Mammaplasty | BreastChina
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Early Stage Breast Cancer | Immunotherapy | Triple Negative Breast Cancer (TNBC) | ProbioticChina
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedStage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Nathalie LevasseurBritish Columbia Cancer AgencyNot yet recruitingBreast Cancer | Breast Cancer Metastatic | Advanced Triple Negative Breast CancerCanada
-
Ohio State University Comprehensive Cancer CenterGateway for Cancer ResearchNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast CancerUnited States
-
National Taiwan University HospitalRecruitingMetastatic Breast Cancer | Premenopausal Breast Cancer | ER Positive Breast CancerTaiwan
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
MedSIRMacroGenics; Seagen Inc.WithdrawnAdvanced Breast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer
-
McMaster UniversityCompletedBreast Cancer Screening | Breast Cancer Diagnosis | MRI Guided Breast BiopsyCanada
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingBreast Cancer | Triple Negative Breast Cancer (TNBC) | Node-positive Breast Cancer | HER2-Negative Breast CarcinomaUnited States
-
Olema Pharmaceuticals, Inc.Novartis PharmaceuticalsRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Australia, Malaysia, Hungary, Romania, South Korea, Spain, United Kingdom, Hong Kong, Canada, Taiwan, Thailand, Greece, Italy, Poland, Austria, Belgium, Czechia, France, Germany, Netherlands, Portugal
-
Forward Pharmaceuticals Co., Ltd.RecruitingMetastatic Breast Cancer | Breast Cancer Stage IV | Locally Advanced Breast Cancer | ER+/HER2- Breast CancerChina
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Pittsburgh; Case Western Reserve...RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Stage III Breast CancerUnited States
-
BioNTech SESeventh Framework ProgrammeCompletedBreast Cancer (Triple Negative Breast Cancer (TNBC))Sweden, Germany
-
AstraZenecaDaiichi SankyoCompletedMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
Xiang ZhangMirati Therapeutics Inc.TerminatedBreast Neoplasms | Triple Negative Breast Cancer | Breast Cancer Stage IV | Breast Cancer MetastaticUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLCTerminatedStage I Breast Cancer | Invasive Breast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Indiana UniversityUniversity of Notre Dame; Elevate Ventures; NearWave Corp.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Carcinoma | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedTriple Negative Breast Cancer | HER2-positive Breast Cancer | TN ER-/PR-/HER2- Breast Cancer | ERany/PRany/HER2+ Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Hunan Cancer HospitalRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Drug Resistance | Treatment Decisions | Hormone Receptor-Positive Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
National Cancer Institute (NCI)TerminatedRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu NegativeUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | HER2-negative Breast Cancer | ER+ Breast Cancer | HER2 Negative Breast CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteThe V Foundation for Cancer ResearchRecruitingHER2-negative Breast Cancer | Breast Cancer Metastatic Breast CancerUnited States